About Me

Dr. Sunil Chopade

MBBS, MD (General Medicine)

DM, Medical Oncology, Tata Memorial Hospital, Mumbai

Dr NB, NBE New Delhi Ex-Assistant Professor, Consultant, Tata Memorial Centre, Mumbai

Doctors Details:-

Designation: Consultant Medical and Hemato Oncologist
Location: Mumbai
Hospital: Jaslok Hospital, Mumbai
Nationality: Indian
Languages: English, Hindi, Marathi

Qualification:-

MBBS, MD (General Medicine)

DM, Medical Oncology, Tata Memorial Hospital, Mumbai

DrNB, NBE New Delhi

Ex- Consultant, Tata Memorial Hospital Mumbai

Dr. Sunil Chopade, completed his MBBS from Government Medical College, Nagpur, then accomplished his MD in General Medicine from Indira Gandhi Government Medical College, Nagpur. Afterwards, he joined the Tata Memorial Hospital Mumbai for his super speciality training in Medical Oncology in 2016. He completed his DM in Medical Oncology in 2019. After completing his training, He worked as assistant professor at Tata Memorial Centre. He also acquired his DrNB (Doctorate of National Board) in Medical Oncology from National Board of Education, Delhi.

Dr. Sunil Chopade is currently working as consultant medical oncologist in Jaslok Hospital, Mumbai.

Dr Sunil Chopade is well experienced Medical Oncologist and Hemato Oncologist. Dr Sunil Chopade completed his under-graduation MBBS from GMC Nagpur and post-graduation in Internal medicine MD from IGGMC Nagpur. He then pursued his super speciality training DM in medical oncology from prestigious institute Tata Memorial Centre, Mumbai. After completing DM in 2019, He was working as Assistant Professor, Consultant Medical Oncology at TMH Mumbai.

He is well trained in medical management of solid organ cancers, lung cancer, breast cancer, head and neck cancers , ovarian cancer, gastrointestinal cancers, urinary cancers and rare cancers like thymomas, neuroendocrine tumour. He is specialised in treating haematological cancers ,leukemias, lymphomas and multiple myeloma. He had his training in hematopoetic stem cell therapy at ACTREC, TMC, Mumbai during his tenure. He has actively participated in the management and containment of COVID-19 in cancer patients and was member of COVID action team at TMH.

Expertise in conventional Chemotherapy, Molecular Targeted therapy, Immunotherapy, and Stem cell transplant therapy for various cancers. He is skilled in oncological procedures.

He received his DrNB in Medical Oncology from National Board of Examinations New Delhi in 2020. He is an ESMO ( European Society of Medical Oncology) Certified Medical Oncologist.

He is member of many national and international societies – ASCO (American Society of Clinical Oncology, ESMO (European Society of Medical Oncology), ISMPO (Indian Society of Medical and Paediatric Oncology), ICON (Indian Cooperative Oncology Network) AMC (Association of Medical Consultants) etc.

He has interest in academics and research. He has been part of various clinical trials and research studies. He has been part of rare cancer clinics, precision medicine and molecular oncology clinics and multidisciplinary tumour boards. He has many research publications in national and international index journal like Journal of Clinical Oncology, Nature. He had presented research posters and abstracts at national and international conferences.

Area of Expertise

Lung Cancer
Bone & Soft Tissue Sarcomas
Gastrointestinal Cancers

Stomach, Colorectal, Hepatobiliary, Esophagus Cancer

Breast Cancer
Gynecological Cancer

Cervix, Uterus, Ovary
Bone Marrow Transplant

Allogeneic Stem Cell Transplant, Autologous Stem Cell Transplant/Stem Cell Transplant

Head & Neck Cancer
Blood Cancers

Lymphoma, Myeloma, Leukemia

Palliative Care
Rare Cancers

Thyroid , Neuroendocrine, Thymoma
Urological Cancer

Renal Cell Cancer, Bladder Cancer, Prostate Cancer & Testicular Cancer - Germ Cell Tumors

My Skills

Medical oncology
Molecular Targeted Therapy
Biological Therapy
Palliative Care & Counselling

Hemat-oncology
Immunotherapy
Stem Cell Transplant Therapy

Chemotherapy
Precision Oncology
Oncological Procedures
Managing COVID 19 in cancer patients

ACADEMICS & CONFERENCES

Paper Presentation: -

• Abstract “Phase III randomised control study evaluating adjuvant metronomic chemotherapy in locally advanced in head and neck cancers post radical chemoradiation (MACE-CTRT ) “ selected for presentation in Poster session at 2022 ASCO (American Society of Clinical Oncology ) Annual Meeting taking place at Chicago, Illinois, USA ( June 2022)

• Faculty and Delegate, 20th Annual Conference Evidence-Based Management of Cancers in India -“Contemporary Management Of Lung Cancer: Hope To Reality” and Musculoskeletal malignancies, Tata Memorial Centre, Mumbai India – February 2022

• Mini Oral Presentation – Abstract “Lymphoepithelioma, lumphoeepithelioma like carcinoma (LELC): Retrospecrtive case series, an experience from tertiary cancer centre.” at National Conference ISMPOCON – January 2022, Mumbai, India

Mini oral Presentation: -

• Mini Oral Presentation and Poster Presentation : Abstract – “Expectations from therapy and disclosure of diagnosis / prognosis in older adults with cancer : A Retrospective cohort study.” at National Conference ISMPOCON – January 2022, Mumbai, India

Conferences & CMEs Attended

• FACULTY AND SPEAKER – YEAR END REVIEW LUNG CANCER CONFERENCE , DECEMBER 2021, MUMBAI, INDIA

• ANNUAL CONGRESS OF IMMUNO-ONCOLOGY SOCIETY OF INDIA, I-OSICON, MUMBAI, 2019 & 2020.

• INDIAN MYELOMA CONGRESS, MUMBAI, MAY -2019.

• YOUNG ONCOLOGIST MEETING (YMO), VISHAKHAPATTANAM, 2018.

• 41ST ICON CONFERENCE, AHMEDABAD, 2019.

• YOUNG HAEMATOLOGIST ORIENTATION PROGRAMME (YHOP), SGPGI, LUCKNOW, 2018.

• MASTERCLASS IN LUNG CANCER, MUMBAI, 2019 & 2020.

• ANNUAL YEAR END REVIEW IN LUNG CANCER CONFERENCE, 2019 & 2020.

• ANNUAL CONFERENCE ON EVIDENCE BASED MEDICINE OF CANCERS IN INDIA, TMH, MUMBAI- HEPATO-BILIARY CANCERS (2019); UROLOGICAL CANCERS (2020); PRECISION ONCOLOGY (2021).

• YEARLY UPDATES OF ASCO AND ESMO MEETINGS.

• REGULAR PARTICIPATION IN MULTIDISCIPLINARY TUMOUR BOARD, MOLECULAR TUMOUR BOARD, RARE CANCERS.

• REGULAR PARTICIPATION IN CME AND WEBINARS IN MEDICAL ONCOLOGY

Clinical Trials

1. Principal Investigator :

Phase III study -“A two-arm : open label prospective parallel design Phase III clinical trial to evaluate the efficacy of a multidisciplinary patient navigation program and symptom monitoring with patient-reported outcomes in lung cancer patients”. Tata Memorial Centre, Mumbai, India

2. Co-Investigator:

An Open-label, Randomized, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Trastuzumab Deruxtecan as First-line Treatment of Unresectable, Locally Advanced, or Metastatic NSCLC Harboring HER2 Exon 19 or 20 Mutations (DESTINY Lung04), Tata Memorial Centre, Mumbai, India.

3. Co-Investigator :

Project Title – Prospective observational study to establish the duration of replication component of SARS-CoV-2 persistence in oncology patients on chemotherapy “ Tata Memorial Centre, Mumbai, India.

Affiliations/Membership

American Society of Clinical Oncology (ASCO) Alexandria, VA

European Society of Medical Oncology (ESMO)

Indian Society of Medical and Pediatric Oncology (ISMPO)

Indian Co-operative Oncology Network (ICON)

Association of Medical Consultants (AMC), Mumbai, India

Publications

1. MD Thesis : “Cognitive impairment in ischemic stroke “

2. Case Blog- Rajashree Khot* and Sunil Chopade’ Heparin induced thrombocytopenia due to low molecular heparin’. International Journal of Clinical and Medical Imaging, Volume 2, Issue 6- 1000330June, 2015;.doi.org/10.4172/2376-0249.1000330

3. Suresh Kumar Bondili, Ravindra Nandhana, Vanita Noronha, Amit Joshi, Vijay Patil, Nandini Menon, Anuradha Chougule, Omshree Shetty, Rajiv Kumar, Pratik Chandrani, Abhishek Mahajan, Sunil Chopade, Kumar Prabhash. Resistance mechanisms to epidermal growth factor receptor inhibitors in non-small cell lung cancer : Cancer Research, Statistics, and Treatment, Year 2020, Volume 3, Issue 4 [p. 801-807] DOI:10.4103/crst.crst_357_20

4. George Abraham, Nandini Sharrel Menon, Sunil R Chopade, Vanita Noronha, Vijay M Patil, Amit Joshi, Kumar Prabhash. A mysterious localized spinal whiteout : Cancer Research, Statistics, and Treatment, Year 2021, Volume 4, Issue 1 [p. 136-138] DOI: 10.4103/crst.crst_365_20

Publications in Pipeline

1. Deviation from standard cancer treatment during the first wave of the COVID-19 Pandemic in India

2. Lung cancer with dual EGFR and ALK driver alterations at baseline

3. Clinical utility of liquid biopsy (cell-free DNA) based EGFR mutation detection post treatment initiation as a disease monitoring tool in patients with advanced EGFR-mutant NSCLC

4. The epidemiological trend of esophageal cancer in Mumbai, India, over the past fifteen years

What Make Us the Best Among Others?

Our patients have praised us for our service, and we have been recognized with national and international recognition.

0 +

Years of Operations

0 +

Specialist

0 +

Awards

0 +

Patients Recovered

Why Choose Us?

We are one of the best health clinics in town, with over 25 certified and qualified doctors serving the community since 1998.